• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测 cN0 单发甲状腺微小乳头状癌侧颈部淋巴结转移的列线图。

A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma.

机构信息

Department of Head and Neck Surgical Oncology, National Cancer Centre, National Clinical Research Centre for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.

Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University/Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Beijing Institute of Otolaryngology, Beijing, China.

出版信息

BMC Cancer. 2023 Aug 1;23(1):718. doi: 10.1186/s12885-023-11219-0.

DOI:10.1186/s12885-023-11219-0
PMID:37528388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10391989/
Abstract

BACKGROUND

Identifying risk factors for occult lateral lymph node metastasis (LLNM) in papillary thyroid microcarcinoma (PTMC) can provide valuable insights into the necessity of lateral neck dissection (LND). The objective of this study was to develop a nomogram for predicting the probability of LLNM in patients with cN0 unifocal PTMC.

METHODS

We conducted a retrospective analyzed a total of 4872 patients with cN0 unifocal PTMC who were treated at our center from January 2013 to June 2018. Logistic regression analysis was used to determine the risk factors for LLNM, and a nomogram was constructed based on these risk factors.

RESULTS

The rate of LLNM was 3.2%. Tumors located in the upper lobe(odds ratio [OR] = 2.56, 95% confidence interval [CI] 1.80-3.62; p < 0.001) and size greater than 7 mm (OR = 2.59, 95% CI 1.85-3.62; p < 0.001) had a significantly higher risk of LLNM compared to tumors in the lower or middle lobe and size less than or equal to 7 mm. Tumors with extrathyroidal extension (ETE) had a significantly higher risk of LLNM (OR = 1.41, 95% CI 1.01-1.99; p = 0.044). The presence of three or more central lymph node metastases (CLNMs) (OR = 5.84, 95% CI 3.83-8.93; p < 0.001) or one or two CLNMs (OR = 2.91, 95% CI 1.93-4.42; p < 0.001) also increased the risk of LLNM compared to having no CLNMs. A nomogram incorporating these risk factors was developed, and the receiver operating characteristic (ROC) curve demonstrated an area under the curve (AUC) of 0.777, indicating a high degree of predictive accuracy.

CONCLUSION

Tumor location in the upper lobe, greater than 7 mm in size, ETE, and CLNMs, especially three or more, were independent risk factors for LLNM in cN0 unifocal PTMC. The nomogram based on these factors exhibited favorable predictive value and consistency.

摘要

背景

识别甲状腺微小乳头状癌(PTMC)隐匿性侧颈部淋巴结转移(LLNM)的危险因素,有助于了解侧颈部清扫术(LND)的必要性。本研究旨在建立预测 cN0 单发 PTMC 患者 LLNM 概率的列线图。

方法

回顾性分析了 2013 年 1 月至 2018 年 6 月在我院接受治疗的 4872 例 cN0 单发 PTMC 患者的临床资料。采用 logistic 回归分析确定 LLNM 的危险因素,并基于这些危险因素建立列线图。

结果

LLNM 的发生率为 3.2%。与下或中叶及直径≤7mm 的肿瘤相比,上叶肿瘤(比值比[OR] = 2.56,95%置信区间[CI] 1.80-3.62;p < 0.001)和直径>7mm 的肿瘤(OR = 2.59,95% CI 1.85-3.62;p < 0.001)LLNM 的风险显著增加。有甲状腺外侵犯(ETE)的肿瘤发生 LLNM 的风险显著增加(OR = 1.41,95% CI 1.01-1.99;p = 0.044)。存在三个或更多中央淋巴结转移(CLNMs)(OR = 5.84,95% CI 3.83-8.93;p < 0.001)或存在一个或两个 CLNMs(OR = 2.91,95% CI 1.93-4.42;p < 0.001)与不存在 CLNMs 相比,LLNM 的风险也会增加。建立了一个包含这些危险因素的列线图,受试者工作特征(ROC)曲线的曲线下面积(AUC)为 0.777,表明具有较高的预测准确性。

结论

肿瘤位于上叶、直径>7mm、ETE 以及中央淋巴结转移,尤其是三个或更多,是 cN0 单发 PTMC 患者发生 LLNM 的独立危险因素。基于这些因素的列线图具有良好的预测价值和一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cd/10391989/98b4738a872c/12885_2023_11219_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cd/10391989/bafbfc2c4328/12885_2023_11219_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cd/10391989/e82c9e8b4938/12885_2023_11219_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cd/10391989/98b4738a872c/12885_2023_11219_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cd/10391989/bafbfc2c4328/12885_2023_11219_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cd/10391989/e82c9e8b4938/12885_2023_11219_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80cd/10391989/98b4738a872c/12885_2023_11219_Fig3_HTML.jpg

相似文献

1
A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma.预测 cN0 单发甲状腺微小乳头状癌侧颈部淋巴结转移的列线图。
BMC Cancer. 2023 Aug 1;23(1):718. doi: 10.1186/s12885-023-11219-0.
2
Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.CN0 期伴有 1-2 枚中央区淋巴结转移的甲状腺乳头状癌患者侧颈淋巴结转移的危险因素及预测模型。
Front Endocrinol (Lausanne). 2021 Oct 15;12:716728. doi: 10.3389/fendo.2021.716728. eCollection 2021.
3
Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.不伴有甲状腺外侵犯的单发微小乳头状甲状腺癌侧颈部淋巴结转移的预测因素。
Asian J Surg. 2019 Apr;42(4):563-570. doi: 10.1016/j.asjsur.2018.07.003. Epub 2018 Aug 3.
4
Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.建立预测甲状腺微小乳头状癌中央区淋巴结转移的列线图。
BMC Cancer. 2024 Feb 20;24(1):235. doi: 10.1186/s12885-024-12004-3.
5
A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma.基于临床病理及超声影像特征的列线图预测cN0期单侧甲状腺微小乳头状癌颈部淋巴结转移
Front Surg. 2021 Dec 3;8:742328. doi: 10.3389/fsurg.2021.742328. eCollection 2021.
6
Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.构建基于甲状腺结节和细针穿刺活检可疑侧颈部淋巴结分布的列线图预测甲状腺乳头状癌转移。
Front Endocrinol (Lausanne). 2023 Nov 28;14:1242061. doi: 10.3389/fendo.2023.1242061. eCollection 2023.
7
Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.甲状腺微小乳头状癌侧颈部淋巴结转移:5241 例随访患者研究。
Endocrine. 2024 Feb;83(2):414-421. doi: 10.1007/s12020-023-03486-5. Epub 2023 Aug 18.
8
What Are the Characteristics of Papillary Thyroid Microcarcinoma Prone to High-Volume Lateral Lymph Node Metastasis? - An Analysis of 2981 Consecutive Cases.哪些特征提示甲状腺微小乳头状癌易发生侧颈部淋巴结转移?——2981 例连续病例分析。
J Invest Surg. 2022 Jul;35(7):1519-1525. doi: 10.1080/08941939.2022.2075494. Epub 2022 May 24.
9
Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.预测甲状腺微小乳头状癌中央区淋巴结转移的列线图:一项回顾性队列研究,纳入 8668 例患者。
Int J Surg. 2018 Jul;55:98-102. doi: 10.1016/j.ijsu.2018.05.023. Epub 2018 May 25.
10
Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis.用于预测有淋巴结转移高风险的 cN0 期甲状腺乳头状癌患者隐匿性转移的列线图。
Adv Clin Exp Med. 2023 Jul;32(7):753-761. doi: 10.17219/acem/157240.

引用本文的文献

1
Evidence-based integration of clinicopathological factors with the risk of papillary thyroid carcinoma lateral cervical lymph node metastasis: systematic review and meta-analysis and subgroup study.基于证据的临床病理因素与甲状腺乳头状癌侧颈淋巴结转移风险的整合:系统评价、荟萃分析及亚组研究
Gland Surg. 2025 May 30;14(5):912-928. doi: 10.21037/gs-2025-60. Epub 2025 May 27.
2
Histopathological findings of 687 thyroid nodules, suspicious for malignancy on ultrasound, with an indeterminate cytopathological diagnosis after the combination of the Bethesda System and mutation status.687个甲状腺结节的组织病理学发现,这些结节在超声检查中可疑为恶性,在结合贝塞斯达系统和突变状态后,细胞病理学诊断不明确。
Cytojournal. 2025 Jan 6;22:1. doi: 10.25259/Cytojournal_97_2024. eCollection 2025.
3

本文引用的文献

1
Risk stratification of lateral neck recurrence for patients with pN1a papillary thyroid cancer.pN1a 期甲状腺乳头状癌患者颈侧区复发的风险分层。
BMC Cancer. 2022 Dec 1;22(1):1246. doi: 10.1186/s12885-022-10326-8.
2
Pattern of Nodal Metastasis in Relation to Size of the Primary Tumour in Well-Differentiated Thyroid Carcinoma.高分化甲状腺癌中淋巴结转移模式与原发肿瘤大小的关系
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2435-2439. doi: 10.1007/s12070-020-02167-3. Epub 2020 Oct 15.
3
Risk Factors for Cervical Lymph Node Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma.
Preoperative circulating tumor cells level is associated with lymph node metastasis in patients with unifocal papillary thyroid carcinoma.术前循环肿瘤细胞水平与单灶性乳头状甲状腺癌患者的淋巴结转移相关。
World J Surg Oncol. 2025 Feb 11;23(1):47. doi: 10.1186/s12957-025-03702-8.
4
Influence of Tumor Laterality and Focality on Clinical Implications and Tumor Advancement in Well-Differentiated Thyroid Cancer.肿瘤侧别和灶性对分化型甲状腺癌临床意义及肿瘤进展的影响
Cancers (Basel). 2024 Dec 7;16(23):4109. doi: 10.3390/cancers16234109.
5
A lasso-based model to predict lateral lymph node metastasis in unifocal papillary thyroid carcinoma with central lymph node metastasis.一种基于套索的模型,用于预测伴有中央淋巴结转移的单灶性乳头状甲状腺癌的侧方淋巴结转移。
Endocrine. 2025 Apr;88(1):185-193. doi: 10.1007/s12020-024-04132-4. Epub 2024 Dec 16.
6
Prediction of lateral neck metastasis in patients with papillary thyroid cancer with suspicious lateral lymph ultrasonic imaging based on central lymph node metastasis features.基于中央淋巴结转移特征对超声成像可疑侧方淋巴结的甲状腺乳头状癌患者侧颈淋巴结转移的预测
Oncol Lett. 2024 Aug 1;28(4):472. doi: 10.3892/ol.2024.14605. eCollection 2024 Oct.
7
A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma.用于预测低危型甲状腺微小乳头状癌不良病理特征的列线图。
BMC Cancer. 2024 Feb 22;24(1):244. doi: 10.1186/s12885-024-12012-3.
中东地区甲状腺微小乳头状癌颈部淋巴结转移的危险因素
J Clin Med. 2022 Aug 8;11(15):4613. doi: 10.3390/jcm11154613.
4
Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.临床隐匿性甲状腺微小乳头状癌中央区淋巴结转移的临床病理预测因素:系统评价和荟萃分析。
World J Surg Oncol. 2022 Apr 1;20(1):106. doi: 10.1186/s12957-022-02573-7.
5
Preoperative and pathological predictive factors of central lymph node metastasis in papillary thyroid microcarcinoma.甲状腺微小乳头状癌中央区淋巴结转移的术前及病理学预测因素。
Auris Nasus Larynx. 2022 Aug;49(4):690-696. doi: 10.1016/j.anl.2021.12.006. Epub 2022 Jan 4.
6
Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.高位甲状腺微小乳头状癌是侧颈部淋巴结转移的危险因素。
Ann Surg Oncol. 2019 Nov;26(12):3992-4001. doi: 10.1245/s10434-019-07587-2. Epub 2019 Jul 1.
7
Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma.单侧N1b期乳头状甲状腺癌的隐匿性对侧侧方淋巴结转移
World J Surg. 2019 Mar;43(3):818-823. doi: 10.1007/s00268-018-4862-9.
8
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.1974 - 2013年美国甲状腺癌发病率和死亡率趋势
JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.
9
Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌淋巴结转移及复发的临床和病理预测因素
Thyroid. 2016 Jun;26(6):807-15. doi: 10.1089/thy.2015.0429. Epub 2016 May 17.
10
Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌淋巴结转移的预测因素
Ann Surg Oncol. 2016 Sep;23(9):2866-73. doi: 10.1245/s10434-016-5225-0. Epub 2016 Apr 13.